Serkan  Kutan net worth and biography

Serkan Kutan Biography and Net Worth

Serkan Kutan serves as Amwell’s Chief Technology Officer where he is responsible for leading the continued development and scaling of Amwell’s telehealth platform. Serkan brings extensive experience in leading technology teams across the healthcare industry and joins Amwell from Haven, a joint venture established by Amazon, Berkshire Hathaway, and JPMorgan Chase, where he was focused on driving rapid innovation through pilots and building a data platform to generate insights. Serkan also served as the CTO of Zocdoc, where he led the transformation of the tech stack, migration to Amazon Web Services and reorganizing the product engineering function which led to significant improvements in product innovation speed and quality. Earlier in his career, Serkan held key technology leadership roles at Amazon, Goldman Sachs and Microsoft. He received his Bachelor’s in Computer Science from Bilkent University in Turkey.

What is Serkan Kutan's net worth?

The estimated net worth of Serkan Kutan is at least $532,409.54 as of February 1st, 2023. Mr. Kutan owns 641,380 shares of American Well stock worth more than $532,410 as of March 28th. This net worth evaluation does not reflect any other assets that Mr. Kutan may own. Learn More about Serkan Kutan's net worth.

How do I contact Serkan Kutan?

The corporate mailing address for Mr. Kutan and other American Well executives is 75 STATE STREET 26TH FLOOR, Boston MA, 02109. American Well can also be reached via phone at 617-204-3500 and via email at [email protected]. Learn More on Serkan Kutan's contact information.

Has Serkan Kutan been buying or selling shares of American Well?

Serkan Kutan has not been actively trading shares of American Well over the course of the past ninety days. Most recently, Serkan Kutan sold 5,444 shares of the business's stock in a transaction on Wednesday, February 1st. The shares were sold at an average price of $3.88, for a transaction totalling $21,122.72. Following the completion of the sale, the chief technology officer now directly owns 641,380 shares of the company's stock, valued at $2,488,554.40. Learn More on Serkan Kutan's trading history.

Who are American Well's active insiders?

American Well's insider roster includes Keith Anderson (CFO), Bradford Gay (VP), Amber Howe (Insider), Deborah Jackson (Director), Kurt Knight (COO), Serkan Kutan (CTO), Paul McNeice (VP), Jason Medeiros (Insider), Mary Modahl (CMO), Brendan O'Grady (Insider), Deval Patrick (Director), Ido Schoenberg (CEO), and Roy Schoenberg (CEO). Learn More on American Well's active insiders.

Are insiders buying or selling shares of American Well?

During the last twelve months, insiders at the sold shares 48 times. They sold a total of 2,176,085 shares worth more than $3,118,721.59. The most recent insider tranaction occured on February, 23rd when insider Kathy Johnson Weiler sold 283,192 shares worth more than $308,679.28. Insiders at American Well own 12.9% of the company. Learn More about insider trades at American Well.

Information on this page was last updated on 2/23/2024.

Serkan Kutan Insider Trading History at American Well

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/1/2023Sell5,444$3.88$21,122.72641,380View SEC Filing Icon  
12/1/2022Sell15,903$3.72$59,159.16646,824View SEC Filing Icon  
11/1/2022Sell4,813$3.99$19,203.87662,727View SEC Filing Icon  
8/1/2022Sell4,896$4.03$19,730.88683,182View SEC Filing Icon  
6/1/2022Sell15,902$3.57$56,770.14688,078View SEC Filing Icon  
4/18/2022Sell19,575$3.58$70,078.50703,980View SEC Filing Icon  
3/1/2022Sell17,893$3.94$70,498.42View SEC Filing Icon  
12/7/2021Sell1,800$6.59$11,862.00View SEC Filing Icon  
See Full Table

Serkan Kutan Buying and Selling Activity at American Well

This chart shows Serkan Kutan's buying and selling at American Well by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

American Well Company Overview

American Well logo
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $0.83
Low: $0.83
High: $0.87

50 Day Range

MA: $1.05
Low: $0.83
High: $1.31

2 Week Range

Now: $0.83
Low: $0.82
High: $2.74

Volume

1,138,961 shs

Average Volume

1,402,818 shs

Market Capitalization

$240.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03